Skip to main content
S 2260 115th Congress Senate Health Charitable contributions Congressional oversight Department of Health and Human Services Drug therapy Drug trafficking and controlled substances Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Income tax credits Medical research National Institutes of Health (NIH) Prescription drugs Research administration and funding Research and development Social work, volunteer service, charitable organizations User charges and fees

Opioids and STOP Pain Initiative Act

Introduced: December 21, 2017 Introduced by: Schatz, Brian Democratic · Hawaii See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 21, 2017
Read twice and referred to the Committee on Finance.
Dec 21, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Opioids and STOP Pain Initiative Act

This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:

  • understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
  • improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
  • supporting the Federal Pain Research Strategy.

NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.

What's happening now December 21, 2017

Read twice and referred to the Committee on Finance.

 Related & companion bills 2
  • HR 5531 Related bill Opioid Emergency Response Act
  • HR 4733 Identical bill Opioids and STOP Pain Initiative Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 2 Independent 1
D
Whitehouse, Sheldon
Rhode Island · Apr 23, 2018
 I
King, Angus S., Jr.
Maine · Apr 16, 2018
 D
Coons, Christopher A.
Delaware · Mar 8, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2260: Opioids and STOP Pain Initiative Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2260/
MLA
"S. 2260: Opioids and STOP Pain Initiative Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2260/.
Bluebook (legal)
S. 2260, 115th Cong. (2026), https://openamerica.io/bill/115-S-2260/.
Markdown link
[S. 2260: Opioids and STOP Pain Initiative Act](https://openamerica.io/bill/115-S-2260/)
Report a problem